Picture of Ultralife logo

ULBI — Ultralife News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousSmall CapNeutral

Ultralife Corp reports results for the quarter ended September 30 - Earnings Summary

* Ultralife Corp  ULBI.OQ  reported quarterly adjusted
earnings of
2 cents​​ per share for the quarter ended September 30, lower
than the same quarter last year, when the company reported EPS
of 10 cents.  The lone analyst forecast for the quarter was
for earnings of 21 cents per share. 
    * Revenue fell 9.6% to $35.69 million from a year ago;
analysts
expected $43.00 million. 
    * Ultralife Corp's reported EPS for the quarter was 2
cents​.
    * The company reported quarterly net income of $258
thousand.
    * Ultralife Corp shares had risen by 2.7% this quarter and
gained 36.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the electrical
components & equipment peer group is also "buy"

Wall Street's median 12-month price target for Ultralife Corp is
$14.00 
This summary was machine generated from LSEG data November 8 at
04:22 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.21           0.02           Missed
 Jun. 30 2024      0.14           0.22           Beat
 Mar. 31 2024      0.10           0.21           Beat
                                  0.18

Recent news on Ultralife

See all news